MATINAS BIOPHARMA HOLDINGS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $8.8M | $61.3M | $21.0M |
| FY2022 | $8.2M | $44.8M | $6.8M |
| FY2023 | $5.9M | $25.1M | $4.8M |
| FY2024 | $5.1M | $12.6M | $7.3M |
| FY2025 | $2.4M | $7.2M | $4.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $8.8M | $61.3M | $21.0M |
| FY2022 | $8.2M | $44.8M | $6.8M |
| FY2023 | $5.9M | $25.1M | $4.8M |
| FY2024 | $5.1M | $12.6M | $7.3M |
| FY2025 | $2.4M | $7.2M | $4.0M |